AUSTRAL Dx is a French start-up developing a new imaging technology based upon airborne ultrasounds which will map vibrations originating from the lungs (directly or via vocal fremitus) or the heartbeat and appearing on the surface of the skin with a precision of 1 micron.
Austral DX has raised €2.5M across 1 funding round from 11 investors, most recently a round in Jul 2025. Based in Paris, France; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-07-24 | Other | €2.5M |
| Aloe Private Equity,Angels Santé,Better Angle,business angel clubs,Business Angels,Capital Cell+5 more |
| View deal → |
